Testing an inherited bone marrow transplant approach for rare blood disorders
Treatments studied
Part of Blood & lymphatic, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This Phase 2 study tests a special “T-cell depleted” transplant plan for people with inherited bone marrow failure disorders (Fanconi anemia or T-Beta-thalassemia—or “TBD”). It may help restore healthy blood production while lowering the chance of certain transplant complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Fanconi anemia or TBD (an inherited bone marrow failure condition)
- Your age is under 65 for Fanconi anemia, or under 70 for TBD
- You have a serious risk situation like severe aplastic anemia, myelodysplasia, a high-risk genetics pattern, or immune problems with frequent infections
- Your heart/lung/liver function is good enough for transplant (the team will check labs and tests)
- You (or your parent/guardian) can sign consent to take part in study procedures
- You are not currently pregnant or breastfeeding (and need a recent negative pregnancy test if you can become pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stem cell transplant using milder chemotherapy (treosulfan and fludarabine) followed by a drug called cyclophosphamide to prevent graft-versus-host disease. It aims to make transplant safer for people with blood diseases who cannot handle standard high-dose chemotherapy.
This Phase 2 study tests a low-intensity bone marrow/stem cell transplant using a matched donor plus two medicines to help prevent the donor cells from attacking you. It aims to treat certain blood cancers—especially when standard treatment has not fully worked or when you are in remission but at higher risk.
This Phase 2 trial tests a stem cell (bone marrow) transplant approach to restore bone marrow function and immune function in people with certain inherited immune problems. If you have one of these conditions and a suitable donor, the study may offer a path to rebuild blood and immune systems.
This Phase 2 study tests a stem cell transplant approach using adjusted chemotherapy doses for people with Fanconi anemia. It may help replace damaged bone marrow and treat blood problems like severe aplastic anemia, MDS, or leukemia.
This Phase 2 study tests a specific type of donor stem cell transplant for severe bone marrow failure conditions, aiming to improve cure rates while reducing transplant risks. It includes people with diseases like severe aplastic anemia and certain bone marrow disorders, especially when standard transplant plans feel too risky.
This trial tests a specialized donor stem cell transplant to treat high-risk problems in the blood and bone marrow, including some cancers and non-cancers. It may help by using donor immune cells designed to better control the disease after transplant.
Hear when a new Fanconi Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.